Clinical (Ahles et al., 2003; Mandelblatt et al., 2018) and preclinical (Demby et al., 2020; Speidell et al., 2019) studies show that APOE4 genotype predisposes to CNS impairments due to cancer chemotherapy. Here, APOE is linked to cancer.